Interestingly, NLRP2 expression was found to be statistically reduced in BA38 of AD patients, the opposite of our NPC results (38% of levels of controls, p = 0.005, Student's t-Test, Fig 6A). This evidence concerns the gene NLRP2 and Alzheimer disease.